Solventum Corp financial data

Symbol
SOLV on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
C/O 3 M Company, 3 M Center, Building 275 6 W 02, St. Paul, MN
State of incorporation
DE
Fiscal year end
December 31
Former names
3M Health Care Co (to 2/9/2024)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 139 %
Quick Ratio 39.9 %
Debt-to-equity 169 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 173M shares
Common Stock, Shares, Outstanding 173M shares
Common Stock, Value, Issued 2M USD
Weighted Average Number of Shares Outstanding, Basic 173M shares +0.41%
Weighted Average Number of Shares Outstanding, Diluted 174M shares +0.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.08B USD +0.39%
Research and Development Expense 189M USD +5%
Costs and Expenses 1.81B USD +15.1%
Operating Income (Loss) 275M USD -45.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 167M USD -66.6%
Income Tax Expense (Benefit) 45M USD +12.5%
Net Income (Loss) Attributable to Parent 122M USD -73.5%
Earnings Per Share, Basic 0.7 USD/shares -73.7%
Earnings Per Share, Diluted 0.7 USD/shares -73.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 772M USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.11B USD
Inventory, Net 953M USD
Other Assets, Current 302M USD
Assets, Current 3.35B USD
Property, Plant and Equipment, Net 1.6B USD
Intangible Assets, Net (Excluding Goodwill) 2.65B USD
Goodwill 6.59B USD
Other Assets, Noncurrent 549M USD
Assets 14.7B USD
Accounts Payable, Current 560M USD
Employee-related Liabilities, Current 251M USD
Accrued Liabilities, Current 450M USD
Contract with Customer, Liability, Current 563M USD
Liabilities, Current 2.9B USD
Deferred Income Tax Liabilities, Net 214M USD
Other Liabilities, Noncurrent 305M USD
Liabilities 11.6B USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -765M USD
Retained Earnings (Accumulated Deficit) 211M USD
Stockholders' Equity Attributable to Parent 3.19B USD -72.4%
Liabilities and Equity 14.7B USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 442M USD -13.2%
Net Cash Provided by (Used in) Financing Activities 462M USD
Net Cash Provided by (Used in) Investing Activities -102M USD -56.9%
Common Stock, Shares Authorized 750M shares
Common Stock, Shares, Issued 173M shares
Common Stock, Par or Stated Value Per Share 0.01 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 802M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 772M USD +1738%
Deferred Tax Assets, Valuation Allowance 22M USD
Depreciation 37M USD -17.8%
Payments to Acquire Property, Plant, and Equipment 102M USD +56.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 300M USD -7.98%
Property, Plant and Equipment, Gross 3.6B USD
Deferred Income Tax Expense (Benefit) -25M USD +26.5%
Additional Paid in Capital 3.74B USD
Amortization of Intangible Assets 88M USD -4.35%
Depreciation, Depletion and Amortization 139M USD -4.14%
Share-based Payment Arrangement, Expense 27M USD +350%